Back
Meta Platforms Vs. Akero Therapeutics Industry Stock Comparison
Buy
61
META
Meta Platforms
Last Price:
$598.20
Seasonality Move:
7.05%
Sell
17
AKRO
Akero Therapeutics
Last Price:
$41.69
Seasonality Move:
-20.18%
Buy
61
Meta Platforms (META)
is a Buy
Is Meta Platforms a Buy, Sell or Hold?
-
The current Meta Platforms [META] share price is $625.66. The Score for META is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
META is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $42.10. The Score for AKRO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
META Stock Price Chart
What is Meta Platforms's stock price today?
-
The Meta Platforms share price today is $625.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and META is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $42.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
META Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -8.08 | Sell |
Relative Strength Index (14 RSI): | 36.52 | Sell |
Chaikin Money Flow: | 9956135 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (656.55 - 719.31) | Sell |
Bollinger Bands (100): | (570.74 - 667.76) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.46 | Buy |
Relative Strength Index (14 RSI): | 40.45 | Sell |
Chaikin Money Flow: | -857514 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.09 - 54.09) | Sell |
Bollinger Bands (100): | (25.41 - 45.17) | Buy |
META Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 650.66 | Sell |
20-day SMA: | 685.78 | Sell |
50-day SMA: | 652.56 | Sell |
200-day SMA: | 565.85 | Buy |
8-day EMA: | 649.38 | Sell |
20-day EMA: | 666.27 | Sell |
50-day EMA: | 654.6 | Sell |
200-day EMA: | 573.33 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.7 | Sell |
20-day SMA: | 48.75 | Sell |
50-day SMA: | 39.78 | Buy |
200-day SMA: | 30.05 | Buy |
8-day EMA: | 45.32 | Sell |
20-day EMA: | 46.41 | Sell |
50-day EMA: | 42.22 | Sell |
200-day EMA: | 33.02 | Buy |
Meta Platforms Earnings Growth & META Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.90 per share, a decrease next quarter of $0.29 per share, an increase this year of $2.57 per share, and an increase next year of $3.82 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.63 per share.
Meta Platforms Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |